Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Pre-NOC submissions
-
We are planning on submitting 2 pieces for pre-NOC review and was wondering if the Health Canada directed requirement for a risk minimization tool (RMT) would count as one of the pre-NOC pieces for review since it isn't a 'usual' PAAB review piece.
-
Moved from About by
Jennifer Carroll
-
Hey @brendaarmit1
No, RMTs would not fall under the 2 core APS. As a reminder, per the pre-NOC submissions guidance, the PM is required to be at Final Draft stage (not expecting any major changes) as confirmed by a letter from the sponsors regulatory department. If changes occur which would impact the piece, the file would be closed and a new file with a new fee would be required.
-
@jennifer-carroll Thank you. So, I just want to be really clear on this. We can submit 2 pre-NOC pieces following the submission guidance and we can submit the RMT pre-NOC for the standard opinion review.
-
Hey @brendaarmit1
You are correct. With the one caveat being that the pieces are still "pre-NOC" so the timeline for review is still at the discretion of PAAB based on file load. Hope that helps.
-
@jennifer-carroll Thank you Jennifer. That does help.